Title: Evaluation of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as potential
markers for ulcerative colitis: a retrospective study
Version: 1 Date: 18 Jun 2022
Reviewer's report:
Feng et al reported two predictive biomarkers, i.e.  NLR and  PLR in the UC.  Frankly, it was
not written well, and with some problems.
1)  There was no novelty of this  research and the results neither showed no superiority as  CRP
and ESR which were the routine non-invasive markers.  MedCalc  software may be proper  for
your team.
2)  TOO many writing inadequacy in the  context and tables. Such as PLR and NLR in the
abstract without full name,  "Facal? calprotectin" in the tables.
Title: Evaluation of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as potential
markers for ulcerative colitis: a retrospective study
Version: 1 Date: 18 Jun 2022
Reviewer's report:
Feng et al reported two predictive biomarkers, i.e.  NLR and  PLR in the UC.  Frankly, it was
not written well, and with some problems.
1)  There was no novelty of this  research and the results neither showed no superiority as  CRP
and ESR which were the routine non-invasive markers.  MedCalc  software may be proper  for
your team.
2)  TOO many writing inadequacy in the  context and tables. Such as PLR and NLR in the
abstract without full name,  "Facal? calprotectin" in the tables.
Please review this paper.
user
Title: Evaluation of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as potential
markers for ulcerative colitis: a retrospective study
Version: 1 Date: 18 Jun 2022
Reviewer's report:
Feng et al reported two predictive biomarkers, i.e.  NLR and  PLR in the UC.  Frankly, it was
not written well, and with some problems.
1)  There was no novelty of this  research and the results neither showed no superiority as  CRP
and ESR which were the routine non-invasive markers.  MedCalc  software may be proper  for
your team.
2)  TOO many writing inadequacy in the  context and tables. Such as PLR and NLR in the
abstract without full name,  "Facal? calprotectin" in the tables.
assistant